Impact of a single-day multidisciplinary clinic on the management of patients with liver tumours

Current Oncology

Volumn 20, Issue 2, 2013, Pages

  Zhang, J ^a   Mavros, M N ^a   Cosgrove, D ^a   Hirose, K ^a   Herman, J M ^a   Smallwood Massey, S ^a   Kamel, I ^a   Gurakar, A ^a   Anders, R ^a   Cameron, A ^a   Geschwind, J F H ^a   Pawlik, Timothy M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Interventional radiology; Liver tumours; Multidisciplinary care; Single day clinic; Surgical oncology

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER CENTER; CANCER LOCALIZATION; CANCER SCINTISCANNING; CLINICAL EVALUATION; CLINICAL FEATURE; COLORECTAL CANCER; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; FOLLOW UP; HEPATOGRAPHY; HUMAN; HUMAN TISSUE; IMAGE QUALITY; LIVER BIOPSY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT ASSESSMENT; PATIENT REFERRAL; POSITRON EMISSION TOMOGRAPHY; TREATMENT PLANNING; TUMOR BIOPSY;

EID: 84875874433     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.20.1297     Document Type: Article

References (41)

1. Gabel M, Hilton NE, Nathanson SD. Multidisciplinary breast cancer clinics. Do they work Cancer 1997;79:2380-4.
2. Chang JH, Vines E, Bertsch H, et al. The impact of a multidisciplinary breast cancer center on recommendations for patient management: the University of Pennsylvania experience. Cancer 2001;91:1231-7.
3. Newman EA, Guest AB, Helvie MA, et al. Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board. Cancer 2006;107:2346-51.
4. Pawlik TM, Laheru D, Hruban RH, et al. Evaluating the impact of a single-day multidisciplinary clinic on the management of pancreatic cancer. Ann Surg Oncol 2008;15:2081-8.
5. Gardner TB, Barth RJ, Zaki BI, et al. Effect of initiating a multidisciplinary care clinic on access and time to treatment in patients with pancreatic adenocarcinoma. J Oncol Pract 2010;6:288-92.
6. Gomella LG, Lin J, Hoffman-Censits J, et al. Enhancing prostate cancer care through the multidisciplinary clinic approach: a 15-year experience. J Oncol Pract 2010;6:e5-10.
7. Korman H, Lanni T Jr, Shah C, et al. Impact of a prostate multidisciplinary clinic program on patient treatment decisions and on adherence to nccn guidelines: the William Beaumont Hospital experience. Am J Clin Oncol 2012;:[Epub ahead of print].
8. Magnani T, Valdagni R, Salvioni R, et al. The 6-year attendance of a multidisciplinary prostate cancer clinic in Italy: incidence of management changes. BJU Int 2012;110:998-1003.
9. Stewart SB, Banez LL, Robertson CN, et al. Utilization trends at a multidisciplinary prostate cancer clinic: initial 5-year experience from the Duke Prostate Center. J Urol 2012;187:103-8.
10. Petty JK, Vetto JT. Beyond doughnuts: tumor board recommendations influence patient care. J Cancer Educ 2002;17:97-100.
11. Gantos-O'Brien E. A patient's perspective on the multidisciplinary liver/pancreas tumor clinic: an all-in-one resort. J Oncol Pract 2010;6:292-4.
12. Junor EJ, Hole DJ, Gillis CR. Management of ovarian cancer: referral to a multidisciplinary team matters. Br J Cancer 1994;70:363-70.
13. Horvath LE, Yordan E, Malhotra D, et al. Multidisciplinary care in the oncology setting: historical perspective and data from lung and gynecology multidisciplinary clinics. J Oncol Pract 2010;6:e21-6.
14. Santoso JT, Schwertner B, Coleman RL, Hannigan EV. Tu-mor board in gynecologic oncology. Int J Gynecol Cancer 2004;14:206-9.
15. Bjegovich-Weidman M, Haid M, Kumar S, Huibregtse C, McDonald J, Krishnan S. Establishing a community-based lung cancer multidisciplinary clinic as part of a large integrated health care system: Aurora Health Care. J Oncol Pract 2010;6:e27-30.
16. Santillan AA, Messina JL, Marzban SS, Crespo G, Sondak VK, Zager JS. Pathology review of thin melanoma and mela-noma in situ in a multidisciplinary melanoma clinic: impact on treatment decisions. J Clin Oncol 2010;28:481-6.
17. Fader DJ, Wise CG, Normolle DP, Johnson TM. The multidisciplinary melanoma clinic: a cost outcomes analysis of specialty care. J Am Acad Dermatol 1998;38:742-51.
18. McGinnis KS, Lessin SR, Elder DE, et al. Pathology review of cases presenting to a multidisciplinary pigmented lesion clinic. Arch Dermatol 2002;138:617-21.
19. Starmer H, Sanguineti G, Marur S, Gourin CG. Multidisci-plinary head and neck cancer clinic and adherence with speech pathology. Laryngoscope 2011;121:2131-5.
20. Friedland PL, Bozic B, Dewar J, Kuan R, Meyer C, Phillips M. Impact of multidisciplinary team management in head and neck cancer patients. Br J Cancer 2011;104:1246-8.
21. Goh P, Harris K, Napolskikh J, et al. New multidisciplinary prostate bone metastases clinic: first of its kind in Canada. Curr Oncol 2007;14:9-12.
22. Sharma RA, Shah K, Glatstein E. Multidisciplinary team meetings: what does the future hold for the flies raised in Wittgenstein's bottle Lancet Oncol 2009;10:98-9.
23. Patkar V, Acosta D, Davidson T, Jones A, Fox J, Keshtgar M. Cancer multidisciplinary team meetings: evidence, challenges, and the role of clinical decision support technology. Int J Breast Cancer 2011;2011:831605.
24. Coenegrachts K, ter Beek L, Haspeslagh M, Bipat S, Stoker J, Rigauts H. Comparison of respiratory-triggered T2-weighted turbo spin-echo imaging versus breath-hold T2-weighted turbo spin-echo imaging: distinguishing benign from malig-nant liver lesions in patients with colorectal cancer. JBR-BTR 2009;92:195-201.
25. Alobaidi M, Shirkhoda A. Benign focal liver lesions: discrimination from malignant mimickers. Curr Probl Diagn Radiol 2004;33:239-53.
26. Heiken JP. Distinguishing benign from malignant liver tumours. Cancer Imaging 2007;7(spec no. A):S1-14.
27. Demirjian A, Peng P, Geschwind JF, et al. Infiltrating he-patocellular carcinoma: seeing the tree through the forest. J Gastrointest Surg 2011;15:2089-97.
28. Kneuertz PJ, Demirjian A, Firoozmand A, et al. Diffuse infil-trative hepatocellular carcinoma: assessment of presentation, treatment, and outcomes. Ann Surg Oncol 2012;19:2897-907.
29. Bomeisl PE Jr, Alam S, Wakely PE Jr. Interinstitutional con-sultation in fine-needle aspiration cytopathology: a study of 742 cases. Cancer 2009;117:237-46.
30. Layfield LJ, Jones C, Rowe L, Gopez EV. Institutional review of outside cytology materials: a retrospective analysis of two institutions' experiences. Diagn Cytopathol 2002;26:45-8.
31. Kojiro M. Focus on dysplastic nodules and early hepatocel-lular carcinoma: an Eastern point of view. Liver Transpl 2004;10(suppl 1):S3-8.
32. Koelma IA, Nap M, Huitema S, Krom RA, Houthoff HJ. Hepa-tocellular carcinoma, adenoma, and focal nodular hyperplasia. Comparative histopathologic study with immunohistochemical parameters. Arch Pathol Lab Med 1986;110:1035-40.
33. Chu PG, Ishizawa S, Wu E, Weiss LM. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Am J Surg Pathol 2002;26:978-88.
34. Nakhleh R, Coffin C, Cooper K. Recommendations for quality assurance and improvement in surgical and autopsy pathology. Am J Clin Pathol 2006;126:337-40.
35. Halappa VG, Bonekamp S, Corona-Villalobos CP, et al. Intrahepatic cholangiocarcinoma treated with local-regional therapy: quantitative volumetric apparent diffusion coefficient maps for assessment of tumor response. Radiology 2012;264:285-94.
36. Mayo SC, de Jong MC, Bloomston M, et al. Surgery versus intra-arterial therapy for neuroendocrine liver metasta-sis: a multicenter international analysis. Ann Surg Oncol 2011;18:3657-65.
37. Pawlik TM, Reyes DK, Cosgrove D, Kamel IR, Bhagat N, Ge-schwind JF. Phase ii trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma. J Clin Oncol 2011;29:3960-7.
38. De Jong MC, Farnell MB, Sclabas G, et al. Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy: a dual-center analysis. Ann Surg 2010;252:142-8.
39. Horvath LE, Yordan E, Malhotra D, et al. Multidisciplinary care in the oncology setting: historical perspective and data from lung and gynecology multidisciplinary clinics. J Oncol Pract 2010;6:e21-6.
40. Berry MG, Chan SY, Engledow A, et al. An audit of patient acceptance of one-stop diagnosis for symptomatic breast disease. Eur J Surg Oncol 1998;24:492-5.
41. Frost MH, Arvizu RD, Jayakumar S, Schoonover A, Novotny P, Zahasky K. A multidisciplinary healthcare delivery model for women with breast cancer: patient satisfaction and physical and psychosocial adjustment. Oncol Nurs Forum 1999;26:1673-80.